Status:
COMPLETED
Improving Vaccine Counseling Skills Among Residents Using Educational Modules and Standardized Patient Encounters
Lead Sponsor:
Corewell Health East
Collaborating Sponsors:
Merck Sharp & Dohme LLC
Conditions:
Vaccine Refusal
Vaccine-Preventable Diseases
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Unfortunately, only 40% of US pediatric residency programs reported in a survey that vaccine safety and counseling training is provided to residents. The success of a residency curriculum focused on c...
Detailed Description
The World Health Organization (WHO) defines vaccine hesitancy (VH) as "the reluctance or refusal to vaccinate despite the availability of vaccines" and included it in the list of top ten threats to gl...
Eligibility Criteria
Inclusion
- Pediatric, medicine/pediatric, and family medicine residents of all training levels
- Employed by Beaumont Hospitals - Royal Oak, Troy, Wayne, or Grosse Pointe.
Exclusion
- Residents not enrolled in pediatric, medicine/pediatric, or family medicine programs
- Residents receiving training at hospitals other than Beaumont Hospital - Royal Oak, Troy, Wayne, or Grosse Pointe.
Key Trial Info
Start Date :
April 25 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 27 2025
Estimated Enrollment :
112 Patients enrolled
Trial Details
Trial ID
NCT06074237
Start Date
April 25 2024
End Date
June 27 2025
Last Update
October 30 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Beaumont Health System
Royal Oak, Michigan, United States, 48073